ALDH2 and cancer: When current or former flushing individuals were considered to have inactive ALDH2, the sensitivity and specificity of the test were 84.8% and 82.3%, respectively, for the esophageal SCC patients and 90.1% and 88.0%, respectively, for the cancer‐free population.